Xenbase is undergoing scheduled maintenance Wednesday, June 14 and Thursday, June 15, 2023. Xenbase will be unavailable on those days.

Click on this message to dismiss it.
Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Xla Wt + rmnd5a MO, Hantel F et al. (2022)

Experiment + Assay: Xla Wt + rmnd5a MO + NF32 (in situ hybridization)
Background: Xla.Outbred
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection rmnd5a MO1 rmnd5a (Xla)
NF stage 2 (2-cell) blastomere
Assay Type Assay Stages Antibody
in situ hybridization NF stage 32 to NF stage 32  
Anatomical Phenotypes: abnormal brain , abnormal eye , decreased size of the eye
Expression Phenotypes (2):
decreased amount pax6.L expression in brain
decreased amount pax6.L expression in eye
Human Disease Associations: neural tube defect, microphthalmia
Source: Fig.6.E-F
Article: XB-ART-59107, PubMed